Physician profile
David A Frankel
NPI 1063696839
$6,864.77
in general payments reported to CMS, 2019-2025
31 companies · $788 in 2025
The $788 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,184 · 2020: $832 · 2021: $564 · 2022: $1,949 · 2023: $1,023 · 2024: $525 · 2025: $788.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,335.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,973.72 | 2019-2025 | Gore Tag Thoracic Branch Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis |
| Medtronic, INC. | $1,203.17 | 2021-2025 | Venaseal, Endurant Iis, Sphere-9 |
| Abbott Laboratories | $972.07 | 2020-2022 | |
| Silk Road Medical, INC. | $566.93 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Cook Medical LLC | $480.11 | 2019-2022 | |
| Medtronic Vascular, INC. | $206.07 | 2019-2020 | |
| Baxter Healthcare | $160.17 | 2019-2025 | Preveleak |
| Inari Medical, INC. | $146.15 | 2022-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Janssen Pharmaceuticals, INC | $138.87 | 2019-2022 | |
| Bard Peripheral Vascular, INC. | $129.86 | 2019-2025 | Crosser Iq, Rotarexs 6 F X 135 Cm |
| Reflow Medical INC | $128.70 | 2024-2025 | |
| Boston Scientific Corporation | $128.66 | 2020-2023 | Varithena Administration Pack |
| Angiodynamics, INC. | $76.09 | 2022-2023 | Alphavac |
| Bolton Medical INC | $70.75 | 2023 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Lemaitre Vascular, INC. | $53.53 | 2020-2024 | Artegraft Vascular Graft |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $44.08 | 2023-2024 | Restrata Wound Matrix |
| Shockwave Medical, INC | $41.70 | 2025 | |
| Davol INC. | $38.94 | 2024 | Venclose Maven Catheter |
| Stryker Corporation | $31.90 | 2025 | Artix Mt |
| Cardiovascular Systems INC. | $31.70 | 2021-2022 | |
| Penumbra, INC. | $30.00 | 2019 | |
| Terumo Medical Corporation | $29.85 | 2019 | |
| Getinge USA Sales, LLC | $28.12 | 2019 | |
| Kerecis Limited | $22.50 | 2022 | |
| Philips North America LLC | $20.40 | 2025 | Visions 014 |
| Medline Industries LP | $19.96 | 2019 | |
| Kci USA, INC. | $19.47 | 2022 | |
| Cvrx, INC. | $18.50 | 2025 | Barostim Neo System |
| Teva Pharmaceuticals USA, INC. | $18.46 | 2022 | |
| Artivion, INC. | $17.29 | 2025 | Photofix Decellularized Bovine Pericardium, Vascular |
| E.R. Squibb & Sons, L.L.C. | $17.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Frankel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.